Transition of Anti-pertussis Antibodies and the Safety of Japanese Diphteria-acellular Pertussis-Tetanus Vaccine administered in reduced doses among Adults
Not Applicable
- Conditions
- pertussis
- Registration Number
- JPRN-UMIN000010779
- Lead Sponsor
- ational Hospital Organization Saitama National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
The person who is infected a malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method increased anti-pertussis antibodies titer after vaccination
- Secondary Outcome Measures
Name Time Method relative frequency of side effects after vaccination